secwatch.observer — SEC 8-K summary
======================================

Issuer:     CorMedix Inc. (CRMD)
CIK:        0001410098
Form:       8-K
Filed at:   2026-07-02T20:30:35+00:00
Accession:  0001410098-26-000040
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CorMedix appoints Elizabeth Hurlburt as Chief Operating and Commercial Officer; Michael Seckler departs
--------------------------------------------------------------------------------

- Elizabeth Hurlburt, previously COO, appointed to newly created role of Chief Operating and Commercial Officer, effective June 29, 2026.
- Hurlburt will oversee commercial, medical affairs, regulatory, and clinical functions, reporting to Chairman & CEO Joseph Todisco.
- Michael Seckler has left the Company as part of the leadership restructuring.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410098/000141009826000040/0001410098-26-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410098/000141009826000040/crmd-20260629.htm
  HTML page:      https://secwatch.observer/filing/0001410098-26-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer